- Brain and Spine Care
-
- Brain and Spine Diagnosis
- Brain Tumor Care
- Deep Brain Stimulation (DBS)
- Endovascular Surgery
- Epilepsy Care
- Gamma Knife® Radiosurgery
- Laser Interstitial Thermal Therapy (LITT)
- Movement Disorder Care
- MRI-guided Focused Ultrasound
- Neurotrauma and Neurocritical Care
- Neurovascular Care
- Spinal Fusion
- Spine Care
- Stroke Care
- Clinical Trials
- Team
- Locations
- Support Services
- Brain and Spine Risk Quizzes
STaRT Registry
This trial aims to measure the effectiveness and safety of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) through clinical and patient-reported outcomes. To qualify for entry, your treatment must include the maximum safe resection of intracranial neoplasm(s) and implantation of GammaTiles™
GESTALT
This trial seeks to explore the effectiveness of GammaTitles™ in diagnosed glioblastoma patients and the safety of dose escalation and intensification. To qualify for entry, you must be at least 18 years old and diagnosed with glioblastoma. If you feel you qualify for this trial, talk with your physician about other entry requirements.
NRG-BN012
This trial studies the effect of stereotactic radiosurgery, a form of radiation therapy that applies radiation only to the areas of cancer and not the surrounding brain tissue, before and after surgery in patients with cancer that has spread to the brain. To qualify for entry, you must be at least 18 years old with confirmed brain metastases. If you feel you qualify for this trial, talk with your physician about other entry requirements.
MODEL
This trial studies the effectiveness of SB-01 injections in patients with chronic lower back pain and Lumbar Degenerative Disc Disease. To qualify for entry, you must be at least 18 years old with a history of severe back pain or diagnosed Lumbar Degenerative Disc Disease. If you feel you qualify for this trial, talk with your physician about other entry requirements.
OCEANIC-STROKE
This trial studies the effectiveness of Asundexian, an anticoagulant, to prevent Ischemic strokes. To qualify for entry, you must be at least 18 years old. If you feel you qualify for this trial, talk with your physician about other entry requirements.
REcurrent Brain Metastases After SRS Trial
This trial examines how well two different treatment plans work for patients with brain metastases. To qualify for entry, you must be at least 18 years old and have brain metastases confirmed by imaging, stemming from cancer outside the central nervous system. If you feel you qualify for this trial, talk with your physician about other entry requirements.
